EVE Health Group Limited

Company Profile

Sector

Consumer Defensive

Industry

Packaged Foods

Employees

N/A

Website

www.evehealthgroup.com.au

Country

Australia

Exchange

ASX

EVE Health provides the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain) Libbo, a proprietary pharmaceutical-grade oral dissolving film formulation for the treatment of erectile dysfunction

Lactobacillus rhamnosus Beebiotic MAP01, a proprietary strain to support digestive health and vitality. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.

Key Stats

52-Week Range

A$0.01A$0.04

Beta0.48

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-0.01

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.